Skip to content
    DaVita Venture Group logo

    DaVita Venture Group

    Denver, Colorado, United StatesFounded 2020

    DaVita Venture Group (DVG) is the corporate venture capital arm of DaVita, a leading kidney care provider. It invests in, develops, and incubates companies and products that improve care for patients with kidney disease and related conditions, with a focus on digital health, pharmaceuticals, medical devices, and care delivery models.

    38% of their portfolio is in Healthcare. Deal activity increased 200% year-over-year (3 deals in the last 12 months). Average disclosed round size is $59.5M (across 12 rounds with reported amounts).

    Find people at DaVita Venture Group on Goldilocks AI

    Portfolio

    11

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    Connor Williams

    Connor Williams

    Director, Pharma Strategy and Contracting

    Emile Bjerkholt

    Emile Bjerkholt

    Director, Corporate Development

    Jess Cronin

    Jess Cronin

    Senior Director, Strategic Partnerships

    Jovie Katticaran

    Jovie Katticaran

    Director, MedTech Strategy and Contracting

    Nick Rolfes

    Nick Rolfes

    Senior Director, Venture Capital

    Brad Marzullo

    Brad Marzullo

    Vice President, Corporate Development, Venture Capital, and Partnerships

    Mahesh Krishnan

    Mahesh Krishnan

    Group Vice President, DaVita Venture Group

    Tom Musgrave

    Tom Musgrave

    Vice President, Pharma and MedTech Strategy and Contracting

    Alisha Prakash

    Alisha Prakash

    Senior Analyst, Strategic Partnerships

    Faiqa Alam

    Faiqa Alam

    Analyst, Corporate Development

    Israa Dahbour

    Israa Dahbour

    Analyst, Pharma Strategy and Contracting

    Will Tonelli

    Will Tonelli

    Manager, Venture Capital

    Looking for someone who isn't listed here?

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    13 investments
    CompanyRound
    R1 Therapeutics logoR1 TherapeuticsMar 2026 · $77.5MSeries A
    Greater Good Health logoGreater Good HealthMar 2026 · $20.5MDebt
    EElara CaringFeb 2026Unknown
    R1 Therapeutics logoR1 TherapeuticsJan 2026 · $77.5MSeries A
    eGenesis logoeGenesisAug 2025 · $191MSeries D
    PPathalys PharmaAug 2024 · $105MSeries B
    Pathalys logoPathalysJan 2023 · $150MGrowth
    CConsejoSanoDec 2020 · $17MSeries B
    Wellth logoWellthMay 2020 · $10MSeries A
    Heartbeat logoHeartbeat$20MSeries B
    Dock Health logoDock Health$5MSeed
    HHeartbeat Health$20MSeries B
    Greater Good Health logoGreater Good Health$20.5MSeries B

    Looking for the people behind these companies?

    Top Co-Investors

    Last updated: 18 November 2026